Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
Natale P, Palmer SC, Navaneethan SD, et al.
Cochrane Database Syst Rev. Pub. Online 29 Apr 2024.
Leggi
Point-counterpoint: The need for Do-It-Yourself (DIY) Open Source (OS) AID systems in type 1 diabetes management
Forlenza GP, Tabatabai I, Lewis D
Diabetes Technol Ther. Pub. Online 26 Apr 2024.
Leggi
Initiating GLP-1 therapy in combination with freestyle libre provides greater benefit compared to GLP-1 therapy alone
Wright EE Jr, Roberts GJ, Chuang JS, et al.
Diabetes Technol Ther. Pub. Online 26 Apr 2024.
Leggi
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
Sterner Isaksson S, Imberg H, Hirsch IB, et al.
Diabetologia. Pub. Online 26 Apr 2024.
Leggi
Predicting hypoglycemia and hyperglycemia risk during and after activity for adolescents with type 1 diabetes
Bergford S, Riddell MC, Gal R, et al.
Diabetes Technol Ther. Pub. Online 26 Apr 2024.
Leggi
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial
Benhalima K, Beunen K, Van Wilder N, et al.
Lancet Diabetes Endocrinol. Pub. Online 29 Apr 2024.
Leggi
Cardiorenal outcomes and mortality after sodium-glucose cotransporter-2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history
Kim JH, Lyu YS, Kim B, et al.
Diabetes Obes Metab. Pub. Online 21 Apr 2024.
Leggi
Safety of the Pcsk9 inhibitor alirocumab: Insights from 47,296 patient-years of observation
Goodman SG, Steg PG, Szarek M, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. Online 24 Apr 2024.
Leggi
Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Wang J, Li X, Li Y, Lei C
BMC Endocr Disord. Pub. Online 24 Apr 2024.
Leggi
Cross-sectional, case-control and longitudinal associations between exposure to glucagon-like peptide-1 receptor agonists and the dispensing of antidepressants
Almeida OP, Fong Z, Hill Almeida LM, et al.
Diabetes Obes Metab. Pub. Online 23 Apr 2024.
Leggi